A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine.

Authors :: Ross LL
Dretler R
Gerondelis P
Rouse EG
Lim ML
Lanier ER
Source :: AIDS (London, England) [AIDS] 2006 Mar 21; Vol. 20 (5), pp. 787-9.
Publication Year :: 2006

Subjects :: Adult
Antiretroviral Therapy, Highly Active
Drug Resistance, Viral genetics
Humans
Male
HIV Infections drug therapy
HIV Reverse Transcriptase genetics
HIV-1 enzymology
Mutation
Reverse Transcriptase Inhibitors therapeutic use

Full Text Access

Tools